» Articles » PMID: 10537166

Pituitary Lactotroph Adenomas Develop After Prolonged Lactotroph Hyperplasia in Dopamine D2 Receptor-deficient Mice

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1999 Oct 28
PMID 10537166
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberoinfundibular dopamine tonically inhibits PRL expression and secretion from the pituitary gland by the activation of dopamine D2 receptors (D2R) localized on lactotrophs. Mutant female mice that lack D2Rs have persistent hyperprolactinemia but also develop extensive hyperplasia of pituitary lactotrophs and peliosis of the adenohypophysis at 9 to 12 months of age, while age-matched male D2R-deficient mice have no morphologic adenohypophysial lesion. We now report that both female and male D2R-deficient mice 17 to 20 months of age develop pituitary lactotroph adenomas. Of 12 aged female mice examined, all developed monohormonal PRL-immunoreactive neoplasms that had a characteristic juxtanuclear Golgi pattern of PRL staining and loss of the reticulin fiber network. Several of these adenomas were 50-fold larger than normal glands with marked suprasellar extension and invasion of brain but no gross evidence of distant metastases. They also had striking peliosis that was more marked than the lesion seen in the hyperplastic pituitaries of the younger females. These findings demonstrate that a chronic loss of neurohormonal dopamine inhibition promotes the hyperplasia-neoplasia sequence in adenohypophysial lactotrophs. Our results are analogous to previous data indicating that protracted stimulation of adenohypophysial cells by hormones or growth factors results in proliferation with initial hyperplasia followed by the development of neoplasia. Six aged male D2R-deficient mice had slightly enlarged anterior pituitaries similar in size to normal female glands. However, each case exhibited multifocal, microscopic lactotroph adenomas with strong nuclear immunoreactivity for estrogen receptors and Pit-1 transcription factor. The unexpected development of adenomas in males without preexisting or concomitant hyperplasia suggests that prolonged loss of dopamine inhibition may also cause neoplasia by distinct cellular mechanisms in male and female animals.

Citing Articles

Prolactin: structure, receptors, and functions.

Chasseloup F, Bernard V, Chanson P Rev Endocr Metab Disord. 2024; 25(6):953-966.

PMID: 39476210 DOI: 10.1007/s11154-024-09915-8.


Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells.

Oh J, Osorio R, Jung J, Carrete L, Choudhary N, Lad M Cancers (Basel). 2023; 15(1).

PMID: 36612109 PMC: 9817686. DOI: 10.3390/cancers15010110.


A New Perspective on Regulation of Pituitary Plasticity: The Network of SOX2-Positive Cells May Coordinate Responses to Challenge.

Le Tissier P, Murray J, Mollard P Endocrinology. 2022; 163(8).

PMID: 35713880 PMC: 9273012. DOI: 10.1210/endocr/bqac089.


Schizophrenia and Macroprolactinoma: Is There a Deep Link?.

Bamarinejad A, Nasiri S, Bamarinejad F, Salehidoost R, Zare-Farashbandi E Adv Biomed Res. 2020; 9:38.

PMID: 33072650 PMC: 7532829. DOI: 10.4103/abr.abr_96_20.


The Role of the Dopamine D2 Receptor in Form-Deprivation Myopia in Mice: Studies With Full and Partial D2 Receptor Agonists and Knockouts.

Huang F, Wang Q, Yan T, Tang J, Hou X, Shu Z Invest Ophthalmol Vis Sci. 2020; 61(6):47.

PMID: 32572456 PMC: 7415310. DOI: 10.1167/iovs.61.6.47.